Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited

@article{Walker2018CardiovascularSO,
  title={Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited},
  author={C. Walker and L. Biasucci},
  journal={Postgraduate Medicine},
  year={2018},
  volume={130},
  pages={55 - 71}
}
  • C. Walker, L. Biasucci
  • Published 2018
  • Medicine
  • Postgraduate Medicine
  • ABSTRACT Non-steroidal anti-inflammatory drugs (NSAIDs) have been widely used to treat inflammatory pain for decades. More recently, newer NSAIDs were developed to target the inducible isoform of cyclooxygenase (COX), COX-2, with the aim of reducing gastrointestinal toxicity. While the COX-2 selective inhibitors were effective in reducing pain and gastrointestinal harm, they soon were associated with an increased risk of adverse cardiovascular events. Initially, the view emerged that selective… CONTINUE READING
    COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
    15
    Copper-tolfenamic acid: evaluation of stability and anti-cancer activity
    2

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 170 REFERENCES
    COX-2 and the Kidney
    114
    The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs.
    38
    COX-2 and the kidneys.
    18
    COX-2 and the kidneys.
    58